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Milk contains active molecules with important functional properties as the defensive proteins; 25 
among them are the whey protein lactoferrin and proteins of the milk fat globule membrane 26 
(MFGM) present in buttermilk. The aim of this study has been to investigate the effect of 27 
lactoferrin, whey and buttermilk as modulators of intestinal innate immunity and oxidative 28 
stress on intestinal epithelial cells, to evaluate its potential use for the development of functional 29 
foods. Innate immune Toll-like receptors (TLR2, TLR4 and TLR9) mRNA expression, lipid 30 
peroxidation (MDA+4-HDA) and protein carbonyl levels were analyzed in enterocyte-like 31 
Caco-2/TC7 cells treated for 24 hours with different concentrations of lactoferrin, whey or 32 
buttermilk. None of the substances analyzed caused oxidative damage; however, whey 33 
significantly decreased the levels of lipid peroxidation. Furthermore, both lactoferrin and whey 34 
were able to reduce the oxidative stress induced by lipopolysaccharide. Respect to TLR 35 
receptors, lactoferrin, whey and buttermilk specifically altered the expression of TLR2, TLR4 36 
and TLR9 receptors, with a strong decrease in TLR4 expression. These results suggest that 37 
lactoferrin, whey and buttermilk could be interesting potential ingredients for functional foods 38 
as they seem to modulate oxidative stress and inflammatory response induced by TLRs 39 
activation.  40 
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Bovine milk is the most consumed type of milk, and several dairy products have also been 48 
produced and consumed worldwide for millennia. Evidence from recent studies, systematic 49 
reviews, and meta-analyses indicates that milk and dairy products may reduce or modify the risk 50 
of developing cardiometabolic diseases, overweight, obesity and type 2 diabetes mellitus, and 51 
probably protect against specific types of cancer, such as colorectal cancer (Thorning et al. 52 
2016; Fontecha et al. 2019; Hidayat et al. 2019). Milk, as well as whey and buttermilk, two 53 
important by-products of dairy industry, contain active molecules characterized by having 54 
functional properties (Svanborg et al. 2015). Among them are the defensive proteins, such as the 55 
whey protein lactoferrin, and some proteins located in the milk fat globule membrane (MFGM).  56 
Whey is obtained after casein coagulation in cheese manufacture. Traditionally considered a 57 
waste product, whey proteins are currently being used to improve technological properties of 58 
foods or as an ingredient in functional foods, due to their outstanding functional and nutritional 59 
properties (de Wit 1998). Buttermilk, a dairy by-product released in the butter-making process, 60 
has been also undervalued for many years. However, several studies have shown that it contains 61 
high value-added components, especially the proteins and polar lipids present in the MFGM 62 
(Vanderghem et al. 2010). 63 
Lactoferrin is a glycoprotein present in many exocrine secretions of mammals, such as milk, 64 
saliva and tears (Siqueiros-Cendón et al. 2014), with the ability to bind two ferric atoms per 65 
molecule (Baker and Baker 2004). Lactoferrin develops an antimicrobial function by 66 
sequestering iron and depriving bacteria from it (Orsi 2004, Jenssen and Hancock 2009), and by 67 
altering the permeability of the bacterial outer membrane (Orsi 2004). Lactoferrin exerts 68 
antiviral activity by blocking the virus surface or by hampering their binding to the cellular 69 
receptors (Van der Strate et al. 2001). Lactoferrin is also involved in some immune processes, 70 
such as inhibition of inflammation or promotion of innate and adaptive immune responses 71 
(Legrand et al. 2005; Actor et al. 2009), decreasing the production of reactive oxygen species 72 
and modulating the pro-inflammatory cytokines (Kruzel et al. 2017). 73 
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In the digestive tract, the intestinal epithelium is a critical barrier between the body and 74 
intestinal content, which activates innate immunity responses to maintain its integrity and 75 
physiology (Cario 2008). Toll-like receptors (TLRs) play a key role in the innate immune 76 
system, recognizing microbial-associated molecular patterns (MAMPs) and contributing to 77 
inflammatory responses (Fukata et al. 2009). In this context, TLR2 and TLR4 recognize cellular 78 
components of Gram-positive and Gram-negative bacteria, respectively, while TLR9 detects 79 
specific bacterial DNA motifs. The intestinal epithelium is also a major target for oxidative 80 
damage due to the constant exposure of reactive oxygen species (ROS) generated by luminal 81 
contents (Gill et al. 2010). 82 
Therefore, the aim of the present work has been to determine and compare the effect of whey, 83 
buttermilk and lactoferrin on mRNA expression of several TLRs, and on the oxidative stress of 84 
lipids and proteins in Caco-2/TC7 cells, as a model of human intestinal epithelia. 85 
Materials and methods 86 
Cell culture 87 
This study was carried out in the human cell line Caco-2/TC7, since these cells are an excellent 88 
human enterocyte-like model to study intestinal epithelial physiology (Mesonero et al. 1994). 89 
The cells were cultured at 37 °C in a humidified atmosphere with 5% CO2, and maintained in 90 
high-glucose DMEM, supplemented with 2% L-glutamine (2 mM), 1% penicillin (10,000 91 
U/mL) and streptomycin (10 mg/mL), 1% nonessential amino acids (10 mM), and 20 % fetal 92 
bovine serum (FBS) (Life Technologies, Carlsbad, CA, USA). The cells were passaged 93 
enzymatically (0.25% trypsin-1 mM EDTA), subcultured in 25 cm2 cell culture flasks (Sarstedt, 94 
Nuembrecht, Germany), and seeded at a density of 104 cells/cm2. The experiments were carried 95 
out in cells cultured for 15 days until morphological and functional enterocyte-like 96 
differentiation. The medium was changed 72 h after seeding the cells and then every 48 h. For 97 
the experiments, the cells were seeded in 6-well plates at a density of 2 × 105 cells/well. Cells 98 
were treated for 24 h with FBS-free culture medium containing either different concentrations 99 
of lactoferrin, whey, buttermilk, and/or lipopolysaccharide (LPS) (3 µg/mL) (E. coli 0111:B4; 100 
5 
 
Sigma-Aldrich, St Louis, MO, USA). The samples were analyzed in triplicate in at least three 101 
independent experiments. 102 
Lactoferrin, whey and buttermilk preparation 103 
Bovine lactoferrin was kindly donated by Tatua Nutritionals Company (Morrinsville, New 104 
Zealand). The purity of lactoferrin was checked by SDS-PAGE, which showed a single band 105 
corresponding to a protein of about 80 kDa and purity higher than 90%. Lactoferrin had an iron-106 
saturation below 10%. A concentrated solution of lactoferrin was prepared in ultrapure water 107 
and it was filtered through a low-binding protein 0.22 µm filter. After filtration, the absorbance 108 
of lactoferrin solutions was measured at 280 nm and its concentration determined by 109 
considering an extinction coefficient of 12.7 (280 nm, 1% solution). 110 
The procedure for obtaining buttermilk and whey from raw bovine milk was performed as 111 
previously described (Parrón et al. 2017). Briefly, raw cow milk provided by the dairy industry 112 
Villacorona (El Burgo de Ebro, Zaragoza, Spain) was skimmed in a cream separator (ARR-DES 113 
125, Suministros Químicos Arroyo, Santander, Spain). The cream was stored at 4 °C overnight 114 
and afterwards was churned into butter, obtaining the buttermilk released in the process that was 115 
filtered through cheesecloth and stored at -20 °C until use. Skimmed milk was fractionated into 116 
casein and whey by casein coagulation at 35 °C for 45 min with recombinant chymosin (Chr. 117 
Hansen, Hørsholm, Denmark). The whey fraction was recovered by decanting and filtering 118 
through glass wool, and it was stored at -20 °C until use. Concentrated solutions of whey and 119 
buttermilk were dissolved in ultrapure water and filtered through low-binding protein 0.22 µm 120 
filters before the experiments with cells. 121 
The concentration of lactoferrin in whey and buttermilk was determined by radial 122 
immunodiffusion according to Sánchez et al. (1992). The content of LPS in lactoferrin was 123 





Cell homogenate preparation 127 
For cell homogenate preparation, the cells were resuspended and homogenized with cold Tris-128 
mannitol buffer (200 mM Tris, 500 mM mannitol, a protease inhibitor cocktail (Complete Mini, 129 
EDTA-free; Roche, Barcelona, Spain), 2% sodium azide, 25 mg/mL benzamidine, and 100 mM 130 
phenylmethylsulfonyl fluoride (PMSF)), pH 7.1. Then, the homogenate was disrupted by 131 
sonication (15 1-s bursts, 60 W) and centrifuged for 10 min at 4 °C and 3,000 g, and the 132 
supernatant was taken for lipid peroxidation and protein carbonyl analysis (Latorre et al. 133 
2014b).  134 
Measurement of lipid and protein peroxidation 135 
Caco-2/TC7 cells were treated with lactoferrin, whey or buttermilk at 0.5, 1, 2, 5 or 10 mg/mL 136 
concentration during 24 h. Lipid and protein peroxidation were assayed as previously described 137 
(Latorre et al. 2014b). Therefore, the level of lipid peroxidation was determined by measuring 138 
the concentration of malondialdehyde (MDA) and 4-hydroxyalkenals (4-HDA). Briefly, MDA 139 
+ 4-HDA reacted with N-methyl-2-phenyl-indole and yielded a stable chromophore that was 140 
measured in a spectrophotometer at 586 nm, using 1,1,3,3-tetramethoxypropane as standard. 141 
The results were calculated in nmol of MDA + 4-HDA/mg protein and were expressed as the 142 
percentage of the control value (100%). Protein oxidation was analyzed by carbonyl level 143 
measurement. Cell homogenates were incubated with the classical carbonyl reagent 2,4-144 
dinitrophenylhydrazine (DNPH), and protein carbonylation was measured 145 
spectrophotometrically at 375 nm. The results were calculated in nmol carbonyl groups/mg 146 
protein and were expressed as percentage of the control value (100%). Protein content was 147 
measured by following the Bradford method (Bio-Rad, Hercules, CA, USA). 148 
RNA extraction, reverse transcription and real-time PCR 149 
Total RNA was extracted from cells cultured in 6-well plates (15 days after seeding) as 150 
previously described (Latorre et al. 2018), using the RNeasy mini kit and the RNase-free DNase 151 
set from Qiagen and following the manufacturer’s instructions. The extracted RNA (1 μg) was 152 
used as a template for first-strand cDNA synthesis using oligo (dT) primers and a reverse 153 
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transcriptase (qScript cDNA SuperMix - Quanta Biosciences Inc., Gaithersburg, MD, USA). 154 
cDNA obtained by reverse transcription (RT) were used to determine TLR2, TLR4 and TLR9 155 
mRNA expression levels by StepOne Plus Real-Time PCR System (Life Technologies, Paisley, 156 
UK), using SYBR Green, with GAPDH and HPRT1 as housekeeping genes. The specific 157 
primers used are detailed in Table 1. Each sample was run in triplicate, and the mean Ct was 158 
determined from the three runs. Relative mRNA expression under each experimental condition 159 
(control or treatment) was expressed as ΔCt = Ctgene − Ctcalibrator. Then, relative mRNA 160 
expression was calculated as ΔΔCt = ΔCttreatment – ΔCtcontrol. Finally, the relative gene expression 161 
levels were converted and expressed as fold difference (=2-ΔΔCt). 162 
Statistical analysis 163 
The results are expressed as mean ± standard error (SE) of the mean. Statistical comparisons 164 
were performed using one-way ANOVA followed by the Dunnett post-test with a confidence 165 
interval of 95 % (p < 0.05), and normal distribution was previously confirmed with the 166 
D'Agostino–Pearson test. Statistical analysis is indicated in each figure and was developed with 167 
the computer-assisted Prism GraphPad Program (Prism version 7.0, GraphPad Software, San 168 
Diego, CA, USA). 169 
Results  170 
Effect of lactoferrin, whey and buttermilk on lipid and protein oxidation 171 
The results show that Caco-2/TC7 cells treated with different concentrations of lactoferrin or 172 
buttermilk display a slight increase in the oxidation of proteins, while treatment with whey 173 
shows a small decrease; however, none of these differences were significant at any of the 174 
concentrations assayed, compared with the control (Figure 1A, 1B, and 1C).  175 
Regarding to lipid peroxidation, whey treatment of Caco-2/TC7 cells show a significant 176 
reduction in the oxidation levels at all tested concentrations except at the lowest (0.5 mg/mL) 177 
(Figure 1E). Conversely, but in agreement to previous results, lactoferrin and buttermilk did not 178 
appear to modify the lipid oxidative status of cells in a significant way (Figure 1D and 1F). 179 
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The concentration of lactoferrin found in milk fractions was of 0.91 mg/g of lyophilized whey 180 
and of 0.48 mg/g of lyophilized buttermilk. 181 
Effect of lactoferrin, whey and buttermilk on TLR2, TLR4, and TLR9 mRNA expression 182 
Since lactoferrin has been involved in processes as inhibition of inflammation or promotion of 183 
innate and adaptive immune responses (Legrand et al. 2005; Puddu et al. 2011), we analyzed if 184 
treatment with lactoferrin, whey or buttermilk could alter TLR2, TLR4 and TLR9 mRNA 185 
expression in Caco-2/TC7 cells differentiated into enterocyte-type cells. As shown in Figure 2, 186 
lactoferrin, whey and buttermilk altered the expression of TLR2, TLR4 and TLR9 receptors in a 187 
different and specific way.  188 
None of the treatment of cells with lactoferrin and buttermilk seemed to affect TLR2 mRNA 189 
expression. However, the expression of this receptor was significantly increased by the highest 190 
concentration of whey treatment (10 mg/mL) (Figure 2A). 191 
Analysis of TLR4 mRNA expression level revealed that it was significantly diminished, at the 192 
concentration of 10 mg/mL of lactoferrin, whey and buttermilk (Figure 2B). 193 
Finally, the results obtained show that the concentration of 0.5 mg/mL of buttermilk induces a 194 
significant increase in TLR9 expression. This increase was also observed in cells treated with 195 
lactoferrin, although it was not statistically significant. Oppositely, the highest concentration of 196 
buttermilk tested (10 mg/mL) induced a significant decrease in TLR9 mRNA expression 197 
(Figure 2C). 198 
Effect of lactoferrin, whey and buttermilk on oxidative stress after LPS challenge 199 
Oxidative stress level was measured on basal state of the cells, i.e. in a situation of normal 200 
homeostatic balance. In addition, lactoferrin, whey and buttermilk strongly decreased the 201 
expression of TLR4, mainly at high concentrations. Therefore, we decided to analyze the effect 202 
of lactoferrin, whey and buttermilk on cells previously stimulated with LPS, a major component 203 
of the outer membrane of Gram-negative bacteria recognized by TLR4, which we have 204 
previously shown to increase the oxidation of both proteins and lipids (Latorre et al. 2014b).  205 
9 
 
Then, the cells were treated with LPS (3 µg/mL) and/or lactoferrin, whey and buttermilk (0.5 206 
and 10 mg/mL) throughout the course of 24 h. Interestingly, the results show that the two tested 207 
concentrations of whey and lactoferrin were able to reduced lipid protein oxidation induced by 208 
LPS (Figure 3B). Oxidative damage in proteins yielded by LPS was reverted by lactoferrin at 209 
the highest concentration assayed (10 mg/mL) and by the two concentrations of whey (0.5 and 210 
10 mg/mL) (Figure 3A). In contrast, buttermilk was not able to inhibit or reduce the oxidative 211 
stress produced by LPS treatment. 212 
The concentration of LPS in the 10 mg/mL lactoferrin solution was of 8 x 10-6 μg/mL. 213 
Discussion 214 
Biological systems are normally subjected to a certain level of oxidative stress; however, when 215 
reactive oxygen species exceed certain quantities, some severe physiological disorders can 216 
occur (Park et al. 2017). Consequently, there is great interest in finding natural substances that 217 
can decrease cellular oxidative stress, and thus some vegetal compounds and milk proteins have 218 
been investigated for this purpose. For instance, whey proteins have been proposed as 219 
antioxidants in several foods to replace chemical antioxidants (Hu et al. 2003; Peña-Ramos and 220 
Xiong 2003; Giblin et al. 2019). Therefore, in this study we have investigated in Caco-2/TC7, 221 
the effect of buttermilk, whey and lactoferrin, on their basal oxidative stress and after being 222 
challenged with LPS. We have also evaluated the effect of those compounds on the expression 223 
of Toll-like receptors 2, 4 and 9. 224 
The results obtained showed that the treatment of Caco-2/TC7 cells with whey reduced their 225 
basal oxidative stress, although the reduction was only significant for lipid peroxidation. 226 
Interestingly, our results agree with those obtained by Piccolomini et al. (2012) that evaluated 227 
the protective effect of whey products on ROS levels in Caco-2 cells subjected to H2O2. It was 228 
shown that whey protein isolate and hydrolysate products, at concentrations of 1 and 2 mg/mL, 229 
caused a significant reduction in ROS levels. Another study carried out on the cell line PC12 of 230 
rat adrenal phaeochromocytoma (Jin et al. 2013) demonstrated that whey protein hydrolysates 231 
protected those cells against H2O2-induced oxidative stress, by reducing apoptosis and 232 
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increasing antioxidant enzyme activities. The extensive review by Corrochano et al. (2018) 233 
includes several studies about the activity of whey and whey proteins as antioxidants, as well as 234 
the effect of heat treatments and hydrolysis on such activity. They concluded that although 235 
studies reveal that direct cell exposure to whey samples increases intracellular antioxidants, 236 
such as glutathione; however, in vivo studies are not yet completely conclusive.  237 
The addition of buttermilk or lactoferrin to Caco-2/TC7 cells did not produce any significant 238 
effect on the oxidative stress of proteins and lipids. In the case of buttermilk, our results 239 
disagree with some previous studies that reported antioxidant activity of this by-product 240 
(Conway et al. 2013; Ripollés et al. 2016). However, it has to be considered that in those studies 241 
the antioxidant activity was not evaluated on a cellular model, but by chemical assays. On the 242 
other hand, one study carried out on the human epithelial colon cancer cell line HT-29 showed 243 
that apo-lactoferrin and lactoferrin saturated with selenium were able to regulate the altered 244 
redox state of those cells, by exerting antioxidant activity (Burrow et al. 2011). Those authors 245 
suggested that lactoferrin could be a valuable component as chemopreventive agent or as a 246 
supplement to improve the immunological level. However, our results are not coincident with 247 
those of Burrow et al. (2011); this discrepancy could be explained by the different cell line used 248 
in both studies. 249 
In a model of Caco-2 cells subjected to hydrogen peroxide to mimic the damage produced in 250 
processes with intestinal epithelial injury (Liu et al., 2019), the addition of human recombinant 251 
lactoferrin down-regulated some inflammatory markers and up-regulated intestinal stem cells 252 
and epithelial proliferation markers. Moreover, lactoferrin was also shown to increase the 253 
expression of tight junction proteins and the transepithelial electrical resistance in Caco-2 cells, 254 
along with a decrease in paracellular permeability (Zhao et al. 2019).  255 
Intestinal epithelium is a major target for oxidative damage due to constant exposure of reactive 256 
oxygen species (ROS) generated by luminal contents, including microbiota (Gill et al. 2010). In 257 
this sense, oxidative stress and activation of TLR pathways can mutually promote each other. In 258 
fact, ionizing radiation-induced ROS can increase TLR2 and TLR4 expression through de novo 259 
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protein synthesis pathway (Yoshino and Kashiwakura 2017), while activation of TLR2, TLR3 260 
and TLR4 can enhance the oxidative status of intestinal epithelial cells (Latorre et al. 2014b). 261 
In this work, we have also observed that the expression of the innate immune receptors TLR2, 262 
TLR4, and TLR9, which expression has been demonstrated in Caco-2 cells after certain 263 
stimulus, such as bacteria, virus or specific agonists (Wang et al. 2012; 2008; Latorre et al. 264 
2018; Hiramatsu et al. 2019), was modified by whey, buttermilk and lactoferrin, although in a 265 
different way each of them. Our results show that lactoferrin, whey and buttermilk diminish 266 
TLR4 expression, however, only whey seems to increase TLR2 expression and only buttermilk 267 
might affect TLR9 expression. These results agree, in part, with those obtained in previous 268 
studies, in which the effect of lactoferrin and milk fractions were evaluated on the TLRs of 269 
monocytes and peripheral blood mononuclear cells, respectively (Puddu et al. 2011; Kiewiet et 270 
al. 2017).  271 
Our results show that lactoferrin, whey and buttermilk strongly decrease the expression of 272 
TLR4. In this sense, previous studies have shown that lactoferrin interacts with antigen 273 
presenting cells, thus having an effect on the expression of soluble immune mediators, such as 274 
cytokines, thus regulating inflammation and immunity (Legrand et al. 2005; Puddu et al. 2009). 275 
In fact, it has been demonstrated that blocking TLR2 and TLR4 in monocytes affect the 276 
induction of IL-6 mediated by bovine lactoferrin, which indicates a critical role of lactoferrin in 277 
directing host immune function (Puddu et al. 2011). 278 
As far as TLR2 is concerned, our results showed no effect of lactoferrin or buttermilk; however, 279 
an increase in TLR2 expression was observed in cells treated with high concentrations of whey. 280 
Interestingly, TLR2 has been shown to contribute to epithelial barrier function by different 281 
mechanisms, including the organization of tight junction zonula occludens 1 protein (ZO-1) 282 
(Cario et al. 2004) and the increase of intestinal mucosa repair and renewal (Hörmann et al. 283 




It is of great interest that our results show the opposite effect on the modified expression of 286 
TLR4 and TLR9, decreasing the levels of the former and increasing those of the latter. In other 287 
studies, the effect of bovine lactoferrin on several TLRs on human monocytic leukemia cell line 288 
has been explored, showing a TLR4 activation (Figueroa-Lozano et al. 2018). On the other 289 
hand, it has been reported that TLR9 plays a role in one of the major pathways responsible for 290 
the anti-inflammatory effects of genomic DNA from lactobacilli (Kim et al. 2012), and that 291 
TLR9 in epithelial cells can neutralize inflammatory signals induced by the activation of other 292 
TLRs (Vijay 2018). Therefore, an increase in TLR9 expression, as induced by lactoferrin and 293 
whey could help in the anti-inflammatory effects, even though the effects of lactoferrin have not 294 
been statistically significant. 295 
Except for the whey that reduces lipid peroxidation, our results do not show a significant effect 296 
of lactoferrin, whey or buttermilk on the basal state of cellular oxidation. However, both 297 
lactoferrin and whey have shown an ability to reverse LPS-induced oxidative damage in lipids 298 
and proteins. In the case of lactoferrin, this effect can be exerted by direct binding to LPS, as it 299 
has been proved that lactoferrin neutralizes free LPS, by avoiding the formation of LPS 300 
complexes that activate the TLR4 signaling pathways (Drago-Serrano et al. 2012). In some 301 
studies performed in vivo, Kruzel et al. (2010) showed that lactoferrin attenuated mitochondrial 302 
dysfunction in LPS-treated animals, suggesting a protective role for lactoferrin in mitochondrial 303 
ROS production (Kruzel et al. 2010). 304 
The protective effect of lactoferrin on the action of LPS has been studied in in vitro and in vivo 305 
models. Thus, Hirotani et al. (2008) showed in Caco-2 cells that LPS decreased their barrier 306 
permeability, altering the expression of two key tight junction proteins. The authors also proved 307 
an increase of oxidative damage by LPS, which was attenuated by lactoferrin from human milk. 308 
In the study by Kruzel et al. (2002) provoked a LPS-induced endotoxaemia in mice and 309 
administered intraperitoneally human lactoferrin as a prophylactic, concurrent or therapeutic 310 
event relative to endotoxic shock. It was found that lactoferrin exerted a differential regulation 311 
of pro-inflammatory and anti-inflammatory mediators. 312 
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The content of lactoferrin in the whey and buttermilk fractions used in this study (4.8 and 9.1 313 
µg/ml, respectively, in the most concentrated samples) is very low compared to the assayed 314 
concentrations of lactoferrin. Therefore, the effect of whey and buttermilk observed could be 315 
attributed to the rest of proteins and peptides present, as they are a complex mixture. The 316 
different effect of whey, compared to buttermilk, in the reversion of LPS-induced oxidative 317 
damage in lipids and proteins could be related with the presence in whey of glycomacropeptide 318 
(GMP). This compound is released from kappa-casein by the enzymatic action of chymosin 319 
when casein is coagulated in cheese manufacture. In some studies GMP, and specially its 320 
hydrolysates, have been proposed to have a modulatory activity on macrophage TLR4 and 321 
potential LPS inhibitors (Cheng et al. 2015). These results suggest that the effects of lactoferrin 322 
and whey may be evident in tissues that have been exposed to inflammatory or oxidative stress 323 
promoting conditions, as previous studies have concluded for some anti-inflammatory cytokines 324 
such as IL-10 (Latorre et al. 2014a). Moreover, the greater antioxidant effect observed for whey, 325 
in part, may be due to the combination of a strong reduction in TLR4 along with an increase in 326 
TLR2 and TLR9 expression. Thus, a lower expression of TLR4 would add to the beneficial 327 
effects described for TLR2 (Cario et al. 2004; Hörmann et al. 2014) and TLR9 (Kim et al. 2012; 328 
Vijay 2018). 329 
Taking into account that there are few studies on the activity of milk proteins on oxidative stress 330 
and TLR expression, and since our results show some contradictory effects depending on the 331 
TLR analyzed, it should be necessary to carry out further experiments to wide our knowledge 332 
on the influence of dairy fractions and proteins on the innate immune system, as well as the 333 
inflammatory responses of tissues, such as the intestine. 334 
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Table 1. Primer sequences used for real-time PCR analysis of expression of Toll-like receptor 522 
and housekeeping genes in Caco-2/TC7 cells.  523 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
Amplicon 
size (bp) 
TLR2 GAAAGCTCCCAGCAGGAACATC GAATGAAGTCCCGCTTATGAAGACA 146 
TLR4 TTGAGCAGGTCTAGGGTGATTGAAC ATGCGGGACACACACACTTTCAAATA 143 
TLR9 AGTCCTCGACCTGGCAGGAA GCGTTGGCGCTAAGGTTGA 168 
HPRT1 CTGACCTGCTGGATTACA GCGACCTTGACCATCTTT 256 
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Figure captions 540 
Fig, 1. Effect of lactoferrin, whey and buttermilk on protein oxidation (A-C) and lipid 541 
peroxidation (D-E). Caco-2/TC7 cells were treated during 1 day with lactoferrin, whey or 542 
buttermilk at 0.5, 1, 2, 5 or 10 mg/mL. Results were expressed as the percentage of the control 543 
value (100%) and were indicated as the mean ± SE of three independent experiments. *p < 0.05, 544 
**p < 0.01 and ***p < 0.001, compared with control. 545 
Fig. 2. Real-time PCR analysis of TLR2, TLR4 and TLR9 mRNA expression: modulation by 546 
lactoferrin, whey and buttermilk treatment. Caco-2/TC7 cells were treated with lactoferrin, 547 
whey or buttermilk at either 0.5 or 10 mg/mL concentration during 1 day. Relative 548 
quantification of mRNA expression was performed using comparative Ct method (2–ΔΔCt). 549 
Results are expressed as arbitrary units (control = 1) and are the mean ± SE of three independent 550 
experiments. *p < 0.05 and ***p < 0.001 compared with the corresponding control. 551 
Fig. 3. Effect of lactoferrin (LF), whey (W), buttermilk (BM) and/or LPS on protein oxidation 552 
(A) and lipid peroxidation (B). Caco-2/TC7 cells were treated during 1 day with either LPS 3 553 
μg/mL and/or lactoferrin (LF), whey (W) or buttermilk (BM) at two concentrations, 0.5 and 10 554 
mg/mL. Results were expressed as the percentage of the control value (100%) and were 555 
indicated as the mean ± SE of four independent experiments. **p < 0.01 and ***p < 0.001, 556 
compared with control. #p < 0.05, ##p < 0.01, and ###p < 0.001 compared with LPS treatment. 557 
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